Thermo Fisher Scientific Expands Bioanalytical Laboratory Services in Europe

Wednesday, 18 September 2024, 01:15

Bioanalytical laboratory services are expanding, as Thermo Fisher Scientific announces a new facility in Europe. This expansion aims to enhance clinical research capabilities and provide advanced support for pharmaceutical and biotech innovations. The new lab will address growing demands in European markets, ensuring faster project turnaround and improved service delivery.
LivaRava_Medicine_Default.png
Thermo Fisher Scientific Expands Bioanalytical Laboratory Services in Europe

Overview of the Expansion

The PPD™ clinical research business of Thermo Fisher Scientific, the world leader in serving science, has announced a significant expansion of its bioanalytical laboratory services in Europe. This new facility is designed to cater to the increasing needs in the clinical research sector.

Key Features of the New Laboratory

  • State-of-the-art technology
  • Enhanced operational capacity
  • Improved project turnaround times

This development will provide pharmaceutical and biotech companies with faster access to vital research outcomes.

Impact on Clinical Research

Biosanalytical capabilities are crucial for the success of clinical trials, and this new laboratory aims to support pharmaceutical innovations with superior data quality.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe